Hib-DTaP-hepatitis B vaccine - GSK
Alternative Names: Hib-DTP-acellular-hepatitis B vaccine - GSK; Infanrix HepB/Hib; QuintanrixLatest Information Update: 02 Aug 2023
At a glance
- Originator GlaxoSmithKline
- Developer GSK
- Class Haemophilus vaccines; Hepatitis B vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Diphtheria; Haemophilus infections; Hepatitis B; Pertussis; Tetanus
Most Recent Events
- 25 Oct 2004 The CHMP recommends approval of the vaccine in the European Union
- 23 Jun 2003 Preregistration for Diphtheria in United Kingdom (IM)
- 23 Jun 2003 Preregistration for Haemophilus infections in United Kingdom (IM)